Study of Vonorasan for bleeding peptic ulcers
Part of Digestive system clinical trials.
This trial tests a new medicine called Vonorasan to stop bleeding from stomach or duodenal ulcers. If you have an actively bleeding ulcer seen on endoscopy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have signs of upper GI bleeding (like vomiting blood or black stools) within the last 48 hours.
- An endoscopy shows a bleeding ulcer 3 to 20 mm wide, with certain bleeding patterns (Forrest Ia, Ib, IIa, or IIb).
- You are not taking a strong acid-reducing medicine (like omeprazole) or other bleeding treatments before the trial.
- You do not have severe liver, kidney, blood, or other major health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
This trial compares two types of acid-reducing medicines to see which is better at preventing re-bleeding in people who have had severe ulcer bleeding. If you qualify, you would receive either a new acid blocker or a double dose of a standard acid reducer.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
This study compares two medications—vonorasan and esomeprazole—to see which one heals stomach ulcers better after a specific type of endoscopic surgery. The goal is to find the safest and most effective way to help your ulcer recover.
Hear when a new Peptic Ulcer Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.